The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.60
Bid: 68.60
Ask: 68.80
Change: -1.00 (-1.44%)
Spread: 0.20 (0.292%)
Open: 69.00
High: 69.20
Low: 68.40
Prev. Close: 69.60
AXB Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Outcome of Board Meeting

24 Apr 2024 12:52

RNS Number : 8922L
Axis Bank Limited
24 April 2024
 

AXIS/CO/CS/50/2024-25

 

April 24, 2024

 

 

Dear Sir/Madam,

 

REF.:

DISCLOSURE UNDER REGULATIONS 30 OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 ("SEBI LISTING REGULATIONS")

SUB.:

OUTCOME OF BOARD MEETING

 

In reference to our letter no. AXIS/CO/CS/38/2024-25 dated April 18, 2024, and pursuant to Regulations 30 and other applicable provisions of the SEBI Listing Regulations, we hereby inform you that the Board of Directors of Axis Bank Limited ("Bank") at its meeting held today, i.e., April 24, 2024, has recommended a final dividend of Re. 1/- per equity share (face value of Rs. 2/- each) i.e., 50% of the face value, for the financial year ended March 31, 2024, subject to approval of the members of the Bank at the ensuing 30th Annual General Meeting ("AGM"). The dividend, if approved, will be paid within 30 days from the date of conclusion of the AGM.

 

The Board has also approved raising of funds (i) by issue of debt instruments in Indian/Foreign currency including, but not limited to, long term bonds, masala bonds, sustainable/ ESG Bonds (including green bonds), optionally/compulsorily convertible debentures, non-convertible debentures, perpetual debt instruments, AT 1 Bonds, Infrastructure Bonds and Tier II Capital Bonds or such other debt securities as may be permitted under the RBI guidelines from time to time, up to an amount of Rs. 35,000 crore (Rupees thirty-five thousand crore only), in terms of Section 42 of the Companies Act, 2013, the SEBI (Issue and Listing of Non-Convertible Securities) Regulations, 2021 and the SEBI Listing Regulations, subject to approval of the members of the Bank; and (ii) by issue of equity shares/ depository receipts and/or any other instruments or securities representing either equity shares and/or convertible securities linked to equity shares including through Qualified Institutions Placement (QIP)/ American Depository Receipts (ADRs)/ Global Depository Receipts (GDRs) program, preferential allotment or such other permissible mode or combinations thereof as may be considered appropriate by the Board, up to an amount of Rs. 20,000 crore (Rupees twenty thousand crore only), in terms of applicable laws, subject to approval of the members of the Bank and statutory/regulatory bodies, as applicable.

 

The Board meeting commenced at 11:30 am (IST) and the aforesaid proposals were approved at 4:00 pm (IST).

 

This is for your information and records.

 

Thanking You.

 

Yours faithfully,

 

For Axis Bank Limited

 

 

Sandeep Poddar

Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGZDMDMGDZM
Date   Source Headline
25th Apr 20241:41 pmRNSOutcome of Board Meeting
25th Apr 20247:43 amRNSGrant of Stock Options/Units
25th Apr 20247:38 amRNSRe-appointment of Directors
24th Apr 202412:52 pmRNSOutcome of Board Meeting
24th Apr 202412:45 pmRNSFinancial Results
19th Apr 202410:39 amRNSAppointment of Joint Statutory Auditors
18th Apr 20242:39 pmRNSBoard Meeting Intimation
18th Apr 20247:00 amRNSUpdate on Acquisition
10th Apr 20249:49 amRNSPostal Ballot Notice dated April 4, 2024
3rd Apr 202412:09 pmRNSUpdate on Acquisition
14th Mar 20247:00 amRNSChanges in Senior Management
7th Mar 20249:29 amRNSAllotment of Non Convertible Debentures
1st Mar 20245:01 pmRNSIssuance of Non Convertible Debentures
27th Feb 20242:07 pmRNSAppointment of Executive Director
21st Feb 20241:25 pmRNSCredit Rating
14th Feb 202412:39 pmRNSAppointment of Additional Independent Director
24th Jan 202410:53 amRNSRevision in Vesting Period - ESOS
24th Jan 202410:49 amRNSOutcome of Board Meeting - 24012024
23rd Jan 202412:01 pmRNSInvestor Presentation and Press Release
23rd Jan 202411:46 amRNSOutcome of Board Meeting
18th Jan 20242:15 pmRNSCessation
3rd Jan 20243:11 pmRNSBoard Meeting Intimation
15th Dec 20238:36 amRNSCessation
1st Dec 20231:52 pmRNSPostal Ballot Results
22nd Nov 20232:22 pmRNSCredit Rating - ICRA
22nd Nov 20232:22 pmRNSCredit Rating
17th Nov 20237:00 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
1st Nov 20238:36 amRNSPostal Ballot Notice
26th Oct 20232:46 pmRNSPostal Ballot Voting Results
26th Oct 20231:35 pmRNSCessation
26th Oct 202312:56 pmRNSAppointment of Whole Time Director
25th Oct 202312:40 pmRNSRelated Party Transaction
25th Oct 202312:18 pmRNSInvestor Presentation and Press Release
25th Oct 202312:02 pmRNSOutcome of Board Meeting 25102023
17th Oct 202310:00 amRNSCredit Rating
6th Oct 20231:25 pmRNSBoard Meeting Intimation 25102023
3rd Oct 20233:00 pmRNSCredit Rating
3rd Oct 20239:54 amRNSCredit Rating
26th Sep 202312:46 pmRNSPostal Ballot Notice
13th Sep 202310:07 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
18th Aug 202311:17 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
17th Aug 20234:46 pmRNSRBI Approval for appointment of Subrat Mohanty
9th Aug 20231:45 pmRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
9th Aug 202312:36 pmRNSDisclosure Under Reg 30 of SEBI (LODR) Reg, 2015
1st Aug 20234:58 pmRNSResignation of Independent Director
28th Jul 20233:47 pmRNSVoting Results AGM
27th Jul 20231:54 pmRNSOutcome of Board meeting
27th Jul 202310:47 amRNSAppointment
26th Jul 202312:50 pmRNSInvestor Presentation and Press Release
26th Jul 202312:44 pmRNSOutcome of Board Meeting 26072023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.